Puma Biotechnology, Inc.

PBYINASDAQHealthcare● Active

$6.85

$-0.18(-2.56%)

Market Cap$348661274

P/E Ratio—

52W High$7.9

52W Low$3.03

Avg Volume278K

Open$7.17

Beta1.21

Cash on Hand Financials Revenue

Puma Biotechnology, Inc. (PBYI) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PBYI · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$97.5M▼ -3.4% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$29.6M

cashAndCashEquivalents

Short-Term Investments

$67.9M

shortTermInvestments

YoY Change vs Prior Year

-3.4%

vs prior fiscal year

Latest Quarter

$101.6M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$97.5MCash on Hand

Total Debt$28.5MTotal Debt

Net Cash / Net Debt+$69.0MNet Cash Position

Cash vs Debt Ratio

Cash 77%Puma Biotechnology, Inc. cash as % of market cap: 27.97%% · MCap $0BDebt 23%

Puma Biotechnology, Inc. has a net cash position of $69.0M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$97.5M − $28.5M = +$69.0M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

PBYI annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

PBYI cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$97.5M-3.4%

Dec 31, 2024FY$101.0M+5.2%

Dec 31, 2023FY$95.9M+18.3%

Dec 31, 2022FY$81.1M-1.3%

Dec 31, 2021FY$82.1M-12.1%

PBYI cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

PBYI vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Puma Biotechnology, Inc.YOU

PBYI

$97.5M$349M28.0%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Puma Biotechnology, Inc. (PBYI) cash on hand as of December 31, 2025 is $97.5M, comprising $29.6M in cash and cash equivalents (CCE) plus $67.9M in short-term investments — reported as Puma Biotechnology, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Puma Biotechnology, Inc. cash reserves or cash position.

Puma Biotechnology, Inc. annual cash on hand history shows decreased -3.4% in 2025: decreased -3.4% in 2025. Puma Biotechnology, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Puma Biotechnology, Inc. carries total debt of $28.5M against cash of $97.5M, resulting in a net cash position of +$69.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

PBYI cash on hand · 5 questions

As of December 31, 2025, Puma Biotechnology, Inc. (PBYI) has $97,528,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $29,635,000 in cash and cash equivalents (CCE) plus $67,893,000 in short-term investments. Latest quarter (March 31, 2026): $101,600,000. Data sourced from the annual 10-K filing via FMP.

PBYI cash on handPBYI cash reservesPBYI cash 2025how much cash does PBYI have

▸ Source: FMP /balance-sheet-statement · US GAAP · Puma Biotechnology, Inc. · Puma Biotechnology, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025